Gilead Sciences Must Face Consumer Claims Over Older, Lower-Quality Drugs, Court Rules

Gilead Sciences must face thousands of claimants in court who allege the company deliberately delayed development of safer drugs to maximize profits on older drugs, California’s First District Court of Appeal ruled Tuesday.